Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoya Fujita

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 22, 2009
[Drug resistance mediated by survival- and growth-promoting signaling pathways]Naoya Fujita
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2014
[Mechanisms of resistance to molecular targeted drugs]Naoya Fujita
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
In vivo veritas: Bcl-2 and Bcl-X(L)mediate tumor cell resistance to chemotherapyNaoya Fujita, Takashi Tsuruo
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|October 23, 2008
Platelet aggregation in the formation of tumor metastasisTakashi Tsuruo, Naoya Fujita
Journal of Biochemistry|September 21, 2012
The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasisNaoya Fujita, Satoshi Takagi
Cancer Chemotherapy and Pharmacology|June 24, 2003
Survival-signaling pathway as a promising target for cancer chemotherapyNaoya Fujita, Takashi Tsuruo
JMA Journal|November 9, 2023
Wandering PneumoniaNaoya Fujita, Yosuke Ono
JMA Journal|May 14, 2023
Scintigraphic Findings in FGF23-related Hypophosphatemic OsteomalaciaNaoya Fujita, Yosuke Ono
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Cancer metastasis-related molecules and their targeted drugs]Satoshi Takagi, Naoya Fujita
CEN Case Reports|April 3, 2020
Prophylactic amoxicillin for the prevention of meningococcal infection in infants with atypical hemolytic uremic syndrome under treatment with eculizumab: a report of two casesKazuki Tanaka, Naoya Fujita, Satoshi Hibino
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 22, 2009
[Drug resistance mediated by survival- and growth-promoting signaling pathways]Naoya Fujita
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2014
[Mechanisms of resistance to molecular targeted drugs]Naoya Fujita
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
In vivo veritas: Bcl-2 and Bcl-X(L)mediate tumor cell resistance to chemotherapyNaoya Fujita, Takashi Tsuruo
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|October 23, 2008
Platelet aggregation in the formation of tumor metastasisTakashi Tsuruo, Naoya Fujita
Journal of Biochemistry|September 21, 2012
The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasisNaoya Fujita, Satoshi Takagi
Cancer Chemotherapy and Pharmacology|June 24, 2003
Survival-signaling pathway as a promising target for cancer chemotherapyNaoya Fujita, Takashi Tsuruo
JMA Journal|November 9, 2023
Wandering PneumoniaNaoya Fujita, Yosuke Ono
JMA Journal|May 14, 2023
Scintigraphic Findings in FGF23-related Hypophosphatemic OsteomalaciaNaoya Fujita, Yosuke Ono
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Cancer metastasis-related molecules and their targeted drugs]Satoshi Takagi, Naoya Fujita
CEN Case Reports|April 3, 2020
Prophylactic amoxicillin for the prevention of meningococcal infection in infants with atypical hemolytic uremic syndrome under treatment with eculizumab: a report of two casesKazuki Tanaka, Naoya Fujita, Satoshi Hibino
Pageof 21